Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
Clinical trial NCT04270682 · COMPLETED
Trial details
- NCT number
- NCT04270682
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2023-07-13
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.